/*Analytics script */
through highly personalized recommendations that automatically adapt to each individual.
We believe that companies and providers can only achieve the true potential of remote healthcare when they maintain continuous relationships with every patient, empowering them to independently comply with their unique health programs, at scale.
“During my almost 30 years of working in connected health innovation, few platforms or devices have excited me or shown as much promise in significantly impacting chronic disease management as Sweetch.”
Prof Kvedar is Immediate Past Chair of the Board of the American Telemedicine Association (ATA), co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, author of The Internet of Healthy Things and The New Mobile Age, editor-in-chief of Nature’s open access, international, peer-reviewed journal, npj Digital Medicine. Dr. Kvedar is a Professor of Dermatology at Harvard Medical School.
I like that Sweetch customizes the experience for each person to meet their optimal behavioral goals. We are not all the same. Our experience should acknowledge this, particularly concerning chronic diseases such as obesity.
Dr. Stanford is an Associate Professor of Medicine and Pediatrics who practices and teaches at Massachusetts General Hospital (MGH)/ Harvard Medical School (HMS) as one of the first fellowship- trained obesity medicine physicians worldwide. She is one of the most highly cited obesity medicine physician-scientists with over 170 peer-reviewed publications. Dr. Stanford received her BS and MPH from Emory University as an MLK Scholar, her MD from the Medical College of Georgia School of Medicine as a Stoney Scholar, her MPA from the Harvard Kennedy School of Government as a Zuckerman Fellow in the Harvard Center for Public Leadership, and her executive MBA as a merit-based scholarship recipient from the Quantic School of Business and Technology. She completed her Obesity Medicine & Nutrition Fellowship at MGH/HMS after completing her internal medicine and pediatrics residency at the University of South Carolina. She has served as a health communications fellow at the Centers for Disease Control and Prevention and as a behavioral sciences intern at the American Cancer Society. Upon completing her MPH, she received the Gold Congressional Award, the highest honor that Congress bestows upon America’s youth. Dr. Stanford has completed a medicine and media internship at the Discovery Channel. An American Medical Association (AMA) Foundation Leadership Award recipient in 2005, an AMA Paul Ambrose Award for national leadership among resident physicians in 2009, she was selected for the AMA Inspirational Physician Award in 2015. The American College of Physicians (ACP) selected her as the 2013 recipient of the Joseph E. Johnson Leadership Award, and the Massachusetts ACP selected her for the Young Leadership Award in 2015. She is the 2017 recipient of the HMS Amos Diversity Award and Massachusetts Medical Society (MMS) Award for Women’s Health. In 2019, she was selected as the Suffolk District Community Clinician of the Year for the Reducing Health Disparities Award for MMS. She was chosen for The Obesity Society Clinician of the Year in 2020. In 2021, she was awarded the MMS Grant Rodkey Award for her dedication to medical students and the AMA Dr. Edmond and Rima Cabbabe Dedication to the Profession Award, which recognizes a physician who demonstrates active and productive improvement to the profession of medicine through community service, advocacy, leadership, teaching, or philanthropy. She is the 2021 Recipient of the Emory Rollins School of Public Health Distinguished Alumni Award. In 2022, the National Academy of Medicine selected her as a Scholar in Diagnostic Excellence.
“People need hyper-personalized tools to help them navigate their chronic conditions every day. Solving this challenge will undoubtedly lead to better outcomes worldwide.”
Dr. Gabbay serves as the Chief Scientific and Medical Officer at the American Diabetes Association, leading its efforts to drive discovery within the world of diabetes research, care and prevention. He is an Associate Professor of Medicine at Harvard Medical School.
I like that Sweetch customizes the experience for each person to meet their optimal behavioral goals. We are not all the same. Our experience should acknowledge this, particularly concerning chronic diseases such as obesity.
“People need hyper-personalized tools to help them navigate their chronic conditions every day. Solving this challenge will undoubtedly lead to better outcomes worldwide.”
“During my almost 30 years of working in connected health innovation, few platforms or devices have excited me or shown as much promise in significantly impacting chronic disease management as Sweetch.”